查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1978836

携带式医疗影像设备市场：按产品类型、便携性类型、应用和最终用户划分－2026-2032年全球市场预测

Portable Diagnostic Imaging Market by Product Type, Portability Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，携带式医疗影像设备市场价值将达到 277.1 亿美元，到 2026 年将成长至 300 亿美元，到 2032 年将达到 496.9 亿美元，复合年增长率为 8.70%。

主要市场统计数据
基准年 2025 277.1亿美元
预计年份：2026年 300亿美元
预测年份 2032 496.9亿美元
复合年增长率 (%) 8.70%

权威地介绍了由小型化、互联互通和临床工作流程变革驱动的诊断影像快速去中心化进程。

携带式诊断影像技术已从固定于医院放射科的专用设备发展成为涵盖多种设备的生态系统，使诊断能力更贴近患者。这一转变得益于技术的微型化、数位讯号处理的进步以及无线连接技术的成熟，使得设备能够在临床环境、现场环境和家庭环境中可靠运作。因此，医疗服务路径变得更加分散，诊断可以在需要的地方进行，而不是集中在中心医疗机构。

小型化、软体主导的生态系统、模组化互通性和供应链弹性如何共同作用，重塑携带式诊断成像设备的格局？

携带式诊断影像领域正经历着一场由科技主导的剧变，这场变革正在改变临床实务、采购模式和病患诊疗路径。感测器的微型化和低场磁振造影架构的技术进步，使得更轻、更节能的设备成为可能，并能轻鬆部署在狭小空间内。同时，超音波诊断设备也正从笨重的主机发展成为手持式和智慧型手机连接设备，提供极其先进的成像功能，包括人工智慧影像辅助和自动化测量工具。这些创新降低了熟练操作人员的准入门槛，并将潜在用户群扩展到诊断成像专业人员之外。

本研究评估了美国关税措施在 2025 年的变化如何影响医学影像领域的供应链策略、采购权衡和商业性差异化。

美国关税的实施和逐步生效将持续到2025年，这对携带式诊断成像设备供应链中的製造商、经销商和医疗保健采购负责人产生了切实的影响。影响关键零件、原料和组装设备的关税正在衝击成本结构，促使企业重新评估筹资策略，并评估区域性製造地和售后服务地点的财务可行性。在许多情况下，企业正透过供应商多元化、增加库存缓衝或加快组装和测试流程的本地化来应对，以降低惩罚性关税和运输延误带来的风险。

将产品类型、便携性、临床应用、最终用户、技术堆迭和价格范围与策略决策流程。

携带式诊断成像市场的最佳理解方式是透过多层细分，揭示临床需求、产品创新和商业性机会的交汇点。产品类型细分包括各种电脑断层扫描 (CT)、分子影像、磁振造影 (MRI) 配置、超音波格式和 X 光解决方案。在此框架下，CT 又分为锥状射束和螺旋两种架构，分别针对不同的操作流程和空间权衡。分子影像分为正子断层扫描 (PET) 和单光子发射电脑断层扫描 (SPECT)，二者在示踪剂处理和临床应用方面各有不同。磁振造影技术则根据磁场强度和设计目的进一步细分，包括用于传统成像的高场系统、兼顾性能和部署柔软性的中场系统以及优先考虑便携性的创新超低场系统。

美洲、欧洲、中东和非洲以及亚太地区的部署模式和现有基础设施将决定携带式成像技术将在哪些地区广泛应用。

区域趋势对携带式诊断成像技术的应用模式、监管预期和商业策略起着决定性作用。在美洲，尤其重视与现有医院网路的整合、床边超音波诊断设备在急诊和门诊环境中的快速普及，以及奖励处理能力和临床疗效显着提升的报销机制。在该地区，能够与电子健康记录和企业影像平台无缝整合的设备往往是优先考虑的因素，而服务网络和应对力则对供应商的选择产生重大影响。

在竞争激烈的市场格局中，传统製造能力、以硬体为中心的创新以及云端和人工智慧伙伴关係关係的整合正在决定市场领导地位。

携带式诊断影像设备的竞争格局呈现出多元化的特点，既有成熟的原始设备製造商 (OEM)，也有专注于特定领域的创新企业，还有利用软体和人工智慧技术提升诊断价值的敏捷型Start-Ups公司。老字型大小企业通常凭藉其丰富的产品系列、全球服务网络和完善的监管合规体系展开竞争，这些优势有助于医疗机构进行大规模采购。为了维护医疗采购方的信任，这些成熟企业通常会在上市后监测、临床研究和全面的培训项目方面投入大量资金。

为设备製造商和医疗保健领导者提供可操作的策略重点，以确保携带式成像领域的临床部署、供应弹性和可持续的收入来源。

产业领导者应优先考虑整合价值提案，将硬体可靠性、软体驱动的临床效用和强大的售后支援相结合。积极投资于临床证据和独立检验研究，可以加快医院采购委员会和认证机构的认可。同时，模组化产品架构允许软体和连接方式升级，从而延长设备生命週期，并透过託管服务和订阅模式创造持续收入。

采用稳健的混合方法研究途径，结合对关键相关人员的访谈、技术文件的审查和三角测量分析，确保获得可操作且检验的见解。

支持这些发现的研究采用了混合方法，旨在透过对一手和二手调查进行三角验证来确保分析的严谨性。一手调查包括对临床终端使用者、采购负责人以及急诊医学、放射学、居家医疗和军事医疗服务领域的技术专家进行结构化访谈，并辅以与医疗设备製造业的产品经理和供应链负责人进行的咨询。这些对话重点关注各种便携式设备和临床应用的实际性能、可维护性问题以及推广应用障碍。

将技术进步、临床证据和营运韧性作为携带式成像持续成功的决定因素进行整合，得出相关结论。

携带式诊断成像正处于转折点，这得益于技术进步、医疗服务模式的演变以及商业性创新，这些因素共同推动诊断范围超越传统医疗环境。具备可靠硬体、灵活软体生态系统、完善售后服务和明确临床证据的设备，最能满足日益增长的现场诊断需求。因此，市场参与企业必须平衡创新速度与卓越运营，确保新产品上市的同时，配套完善的服务模式与整合方案能有效降低使用者接受度。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：携带式医疗影像设备市场：依产品类型划分

  • CT
    • 锥状射束CT
    • 螺旋CT
  • 分子影像
    • PET
    • SPECT
  • MRI
    • 高磁场
    • 中等磁场
    • 超低磁场
  • 超音波
    • 2D
    • 3D
    • 多普勒
    • 手持式
      • 专用终端
      • 基于智慧型手机
    • 无线的
      • 蓝牙相容
      • 具备 Wi-Fi 功能
  • X射线
    • 电脑放射成像
    • 数位放射线摄影

第九章：按便携性类型分類的携带式医疗影像设备市场

  • 手持式
    • 专用终端
    • 配备智慧型手机的
  • 笔记型电脑安装
    • 标准集成
    • 平板电脑集成
  • 手推车式
    • 交流电源
    • 电池供电

第十章：携带式医疗影像设备市场：依应用领域划分

  • 紧急状况
    • 重症监护
    • 创伤
  • 居家照护
    • 慢性病监测
    • 老年护理
  • 军队
    • 战区
    • 野战医院
  • 护理点
    • 腹部
    • 心臟病学
    • 肌肉骨骼系统
    • 产科
    • 血管
  • 兽医学
    • 大型动物
    • 小动物

第十一章：携带式医疗影像设备市场：依最终用户划分

  • 诊所
    • 政府
    • 私人的
  • 诊断中心
    • 诊断影像中心
    • 检查室
  • 居家照护提供者
    • 私人的
    • 公共机构
  • 医院
    • 整体的
    • 专科医疗部门
  • 门诊部
    • 门诊手术
    • 復原

第十二章：携带式医疗影像设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：携带式医疗影像设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章携带式医疗影像设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国携带式医疗影像设备市场

第十六章：中国携带式医疗影像设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Agfa-Gevaert NV
  • Akumin Inc
  • Butterfly Network, Inc.
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Cobalt Health
  • CurveBeam LLC
  • Esaote SpA
  • Esaote SpA
  • Front Range Mobile Imaging
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc
  • Hitachi Ltd.
  • Hologic, Inc.
  • Hyperfine Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Nox Medical
  • OMRON Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Toshiba Medical Systems Corporation
  • TridentCare, LLC
  • TTG Imaging Solutions, LLC
Product Code: MRR-2A0283E25686

The Portable Diagnostic Imaging Market was valued at USD 27.71 billion in 2025 and is projected to grow to USD 30.00 billion in 2026, with a CAGR of 8.70%, reaching USD 49.69 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 27.71 billion
Estimated Year [2026] USD 30.00 billion
Forecast Year [2032] USD 49.69 billion
CAGR (%) 8.70%

An authoritative introduction to the rapid decentralization of diagnostic imaging driven by miniaturization, connectivity, and clinical workflow transformation

Portable diagnostic imaging has evolved from specialist equipment tethered to hospital imaging suites into a diverse ecosystem of devices that push diagnostic capacity closer to the patient. This transition is driven by technological miniaturization, advances in digital signal processing, and the maturation of wireless connectivity, which together enable devices to operate reliably in clinical, field, and domiciliary settings. As a result, care pathways are becoming more decentralized, with diagnostics delivered at the point of need rather than being concentrated in central facilities.

The convergence of imaging modalities with cloud computing and edge analytics is reshaping clinical workflows and enabling faster triage decisions. Clinicians are using portable CT, MRI variants, ultrasound, molecular imaging, and compact X-ray systems to gather actionable information that previously required patient transport and scheduling delays. From emergency response to home-based chronic disease monitoring, these technologies expand the reach of diagnostic services and support timelier interventions. In parallel, design priorities have shifted toward ergonomic form factors, power efficiency, and simplified user interfaces to minimize training burdens and streamline integration into non-traditional care settings.

Regulatory scrutiny and interoperability standards are increasingly central to product development cycles, and stakeholder expectations for data security and clinical validation are rising. Adoption is therefore mediated not only by device performance, but also by the extent to which vendors can demonstrate robust clinical evidence, reliable lifecycle support, and secure data management. This introduction frames the subsequent analysis by highlighting where the sector is now, the forces shaping near-term competitive advantage, and the operational considerations that will decide which portable imaging solutions achieve broad, sustained adoption.

How miniaturization, software-driven ecosystems, modular interoperability, and supply chain resilience are collectively reshaping portable diagnostic imaging dynamics

The landscape of portable diagnostic imaging is undergoing profound, technology-led shifts that are transforming clinical practice, procurement models, and patient pathways. Technological advances in sensor miniaturization and low-field MRI architectures are enabling devices that are lighter, more energy-efficient, and easier to deploy in constrained environments. Simultaneously, ultrasound systems have progressed from bulky consoles to handheld instruments and smartphone-integrated devices that offer surprisingly sophisticated imaging capabilities, supported by AI-assisted interpretation and automated measurement tools. These innovations lower the barrier to skilled operation and expand the pool of potential users beyond imaging specialists.

Connectivity and software-defined functionality are also creating new value layers. Cloud-enabled platforms and edge computing allow for secure image transfer, remote consultation, and continuous software improvement without hardware replacement. This increases device lifespan and enables subscription-style software monetization. At the same time, modularity and platform approaches are promoting interoperability across modalities, making it simpler for institutions to integrate portable units into existing clinical information systems. Consequently, purchasing decisions are increasingly influenced by a device's ecosystem compatibility and long-term software roadmap rather than by hardware features alone.

Clinical workflow paradigms are shifting as emergency departments, outpatient centers, and home care providers integrate point-of-care imaging to expedite diagnosis. This evolution is supported by reimbursement adjustments in some jurisdictions and by operational incentives to reduce patient throughput times. Finally, supply chain resilience and geographic diversification of component sourcing have become strategic priorities following recent global disruptions, prompting many manufacturers to rethink sourcing strategies and to increase localization of critical components. Together, these transformative shifts are redefining competitive advantage in portable diagnostic imaging and setting the agenda for product roadmaps, commercial models, and regulatory engagement.

Assessing how evolving United States tariff measures through 2025 have reshaped supply chain strategy, procurement trade-offs, and commercial differentiation in imaging

The imposition and evolution of tariffs by the United States through 2025 have had tangible implications for manufacturers, distributors, and healthcare buyers within the portable diagnostic imaging supply chain. Tariffs affecting key components, raw materials, and assembled devices influence cost structures, prompting firms to reassess sourcing strategies and to evaluate the financial viability of regional manufacturing and aftermarket support hubs. In many cases, companies have responded by diversifying supplier bases, increasing inventory buffers, or accelerating localization of assembly and testing processes to mitigate exposure to punitive duties and transit delays.

These shifts are not limited to cost considerations. Tariffs interact with regulatory compliance and logistics complexity to shape go-to-market timing and pricing transparency. Providers that rely on cross-border procurement may encounter longer lead times and more complex warranty administration. Consequently, procurement teams and clinical leaders must weigh the trade-offs between short-term acquisition cost savings and longer-term serviceability, spare-part availability, and lifecycle total cost of ownership. In parallel, firms are revisiting distribution models to reduce tariff drag, for example by establishing regional distribution nodes or by partnering with local contract manufacturers to perform final assembly in tariff-friendly jurisdictions.

Moreover, the tariff environment has intensified competitive differentiation around non-price attributes such as clinical evidence, software services, and integrated training programs. As cost pressures ripple through the value chain, companies that offer robust remote support, predictable maintenance schedules, and clear upgrade paths for cloud and AI-enabled services tend to retain customer trust despite price volatility. Finally, public procurement policies that factor in supply chain security and regional industrial policy are increasingly influencing vendor selection, underscoring the need for transparency and resilience in sourcing and operational planning.

Comprehensive segmentation insights connecting product types, portability formats, clinical applications, end users, technology stacks, and price tiers to strategic decision pathways

The portable diagnostic imaging market is best understood through layered segmentation that reveals where clinical demand, product innovation, and commercial opportunity intersect. Product-type differentiation spans computed tomography variants, molecular imaging, magnetic resonance configurations, ultrasound formats, and X-ray solutions. Within this framework, CT diverges into cone beam and helical architectures, each addressing different procedural and spatial trade-offs. Molecular imaging splits into positron emission tomography and single photon systems, which have distinct tracer logistics and clinical use cases. Magnetic resonance technology is further stratified by field strength and design intent, encompassing high-field systems for conventional imaging, mid-field systems that balance performance and deployment flexibility, and ultra-low-field innovations that prioritize portability.

Ultrasound exemplifies breadth within portability, ranging from traditional two-dimensional devices to three-dimensional and Doppler-capable platforms suited for vascular and cardiology applications. The handheld segment introduces both dedicated devices and smartphone-integrated options, while wireless configurations include Bluetooth-enabled and Wi-Fi-enabled models, each with different implications for connectivity, security, and integration. X-ray follows a similar bifurcation between computed radiography and fully digital radiography approaches, emphasizing differences in image processing workflows and onsite storage requirements. Portability type further segments the market into handheld, laptop-based, and trolley-based solutions; handheld devices differentiate between dedicated hardware and smartphone-based systems, laptop-based systems may be integrated in standard or tablet forms, and trolley-based platforms present AC-operated or battery-operated variants, with corresponding implications for mobility and deployment scenarios.

Application-driven segmentation highlights the clinical contexts where portable imaging delivers the most value. Emergency use cases split into critical care and trauma workflows where rapid diagnostics are essential, while home care supports chronic disease monitoring and elderly care. Military deployments must accommodate combat zone and field hospital constraints, and point-of-care applications cover abdominal, cardiology, musculoskeletal, obstetrics, and vascular indications. Veterinary uses bifurcate into large animal and small animal modalities, each with distinct form factor and durability requirements. End-user segmentation spans clinics, diagnostic centers, home care providers, hospitals, and outpatient centers; within these categories, ownership models and institutional types-government versus private clinics, imaging centers versus laboratories, private versus public home care providers, general versus specialty hospitals, and ambulatory surgical versus rehabilitation outpatient centers-shape procurement cycles and support expectations.

Technology and price-range segmentations also play critical roles. Analog versus digital divides the market along workflow modernization lines, with film-based analog approaches giving way to cloud-enabled and on-premise digital infrastructures that alter image access and archival strategies. Price tiers-from economy low-end devices to mid-range entry and standard models and up to premium and ultra-premium high-end offerings-drive different value propositions, where high-end solutions emphasize advanced imaging capability and comprehensive service contracts, while low-end devices prioritize affordability and basic diagnostic utility. Together, these segmentation lenses provide a detailed map for vendors and buyers to assess where to focus product development, clinical validation, and commercial investment to meet nuanced customer needs.

Regional adoption patterns and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine where portable imaging gains traction

Regional dynamics play a decisive role in adoption patterns, regulatory expectations, and commercial strategies for portable diagnostic imaging. In the Americas, there is a pronounced emphasis on integration with established hospital networks, rapid adoption of point-of-care ultrasound in emergency and ambulatory settings, and a reimbursement landscape that rewards demonstrable improvements in throughput and clinical outcomes. Procurement cycles in this region often prioritize devices that can integrate seamlessly with electronic health records and enterprise imaging platforms, and vendor selection is heavily influenced by service networks and responsiveness.

Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory frameworks, reimbursement incentives, and capital availability vary widely. In parts of Europe, centralized procurement and strong clinical governance favor solutions with robust evidence packages and interoperability credentials. Meanwhile, Middle Eastern markets often prioritize rapid deployment capabilities and localized support, and sub-Saharan African contexts place a premium on durability, energy efficiency, and straightforward maintenance protocols. Across this combined region, opportunities exist for vendors that can offer adaptable service models and durable designs that address infrastructure variability.

Asia-Pacific exhibits dynamic demand driven by urbanization, expanding primary care capacity, and significant investments in healthcare infrastructure. Several countries in the region are advancing telemedicine and home healthcare initiatives that rely on portable imaging for remote diagnostics and chronic care management. Additionally, a growing domestic manufacturing base and evolving regulatory infrastructures influence procurement decisions, with buyers seeking scalable, cost-effective devices that can be supported across diverse geographies. These regional profiles underscore the importance of tailoring product feature sets, service offerings, and commercial approaches to local clinical practices, reimbursement environments, and infrastructure realities.

Competitive landscape dynamics where legacy manufacturing strength, focused hardware innovation, and cloud and AI partnerships converge to determine market leadership

The competitive landscape in portable diagnostic imaging is characterized by a mix of established original equipment manufacturers, specialized niche innovators, and agile startups leveraging software and AI to add diagnostic value. Established firms often compete on breadth of product portfolios, global service networks, and established regulatory pathways that facilitate large-scale procurement by health systems. These incumbents typically invest heavily in post-market surveillance, clinical studies, and comprehensive training programs to maintain trust among institutional buyers.

Concurrently, specialized firms and newer entrants are driving disruption through focused innovations in handheld ultrasound, low-field magnetic resonance systems, and compact CT designs. Their strengths lie in rapid iteration, targeted clinical validation in specific use cases, and business models oriented around software subscriptions and managed services. Partnerships between hardware developers and software or cloud providers are increasingly common, enabling devices to offer enhanced image processing, decision support, and teleconsultation capabilities. This collaboration model lowers barriers for clinical adoption by addressing interpretation bottlenecks and by enabling remote expert support.

Mergers, strategic alliances, and licensing agreements are recurrent themes, as companies seek to combine hardware competencies with advanced software capabilities and regional distribution expertise. Supply chain integration and serviceability remain competitive differentiators, particularly for buyers in decentralized care settings who prioritize uptime and local maintenance. Intellectual property in imaging reconstruction algorithms, low-power hardware designs, and AI-enabled diagnostic aids is also a critical axis of competitive advantage, with firms that can protect and commercialize these assets better positioned to capture long-term value. Overall, the company landscape rewards those who can balance product reliability with software-enabled clinical value and resilient support infrastructure.

Actionable strategic priorities for device makers and healthcare leaders to secure clinical adoption, supply resilience, and recurring revenue streams in portable imaging

Industry leaders should prioritize an integrated value proposition that pairs hardware reliability with software-enabled clinical utility and resilient post-sale support. Investing proactively in clinical evidence generation and independent validation studies will accelerate acceptance among hospital procurement committees and credentialing bodies. At the same time, modular product architectures that allow upgrades to software and connectivity features can extend device lifecycles and create recurring revenue through managed services and subscription models.

Operationally, companies should diversify supply chains and consider regional final assembly or contract manufacturing to mitigate tariff and logistics exposure. Building capacity for remote diagnostics, predictive maintenance, and spare-part forecasting will reduce downtime and strengthen customer trust, especially in decentralized care settings. Commercial strategies should emphasize partnerships with telehealth platforms, electronic health record vendors, and local service organizations to ensure seamless integration and to lower adoption friction for end users. Pricing and reimbursement strategies must be aligned with demonstrated clinical and operational benefits; value-based contracting pilots can help capture part of the efficiency gains delivered by point-of-care imaging.

Finally, investing in training programs, intuitive user interfaces, and clinician-facing decision support will broaden the addressable user base and reduce reliance on specialist operators. By combining clinical validation, software flexibility, supply chain resilience, and service excellence, industry leaders can turn current disruptions into durable competitive advantages and drive broader adoption across both institutional and non-institutional care settings.

A robust mixed-methods research approach combining primary stakeholder interviews, technical document review, and triangulated analysis to ensure actionable and validated insights

The research underpinning these insights employed a mixed-methods approach designed to triangulate primary and secondary evidence and to ensure analytical rigor. Primary research included structured interviews with clinical end users, procurement officers, and technical specialists across emergency medicine, radiology, home care, and military medical services, complemented by consultations with product managers and supply chain leaders in device manufacturing. These conversations focused on real-world performance, serviceability concerns, and adoption barriers across a range of portability formats and clinical applications.

Secondary research involved systematic review of peer-reviewed clinical studies, regulatory filings, product technical specifications, and industry whitepapers that document device performance characteristics, safety profiles, and interoperability features. Where available, authoritative standards and guidance from regulatory agencies were consulted to contextualize compliance requirements and to assess evidence expectations for clinical deployment. Data from logistics and trade publications informed analysis of supply chain patterns and tariff-related impacts, while technology trend reports helped frame developments in miniaturization, connectivity, and AI-enabled image analysis.

Analytical techniques included comparative feature mapping across segmentation lenses, scenario analysis to evaluate supply chain and tariff contingencies, and cross-validation of primary insights against documented product performance. Limitations of the methodology include variability in published clinical evidence across device classes and regional heterogeneity in procurement and reimbursement policies. To mitigate these limitations, findings were validated with multiple independent stakeholders and subjected to sensitivity checks to ensure robustness of conclusions. The resulting framework combines empirical observation with strategic interpretation to support decision-making for manufacturers, providers, and investors.

Concluding synthesis that aligns technology progress, clinical evidence, and operational resilience as the determinants of enduring success in portable imaging

Portable diagnostic imaging is at an inflection point where technological progress, changing care delivery models, and commercial innovation converge to expand diagnostic reach beyond traditional settings. Devices that marry dependable hardware with flexible software ecosystems, strong post-sale support, and clear clinical evidence will be best placed to capture the growing demand for point-of-need diagnostics. Market participants must therefore balance innovation velocity with operational excellence, ensuring that new product introductions are accompanied by service models and integration pathways that reduce adoption friction.

Regulatory, tariff, and supply chain pressures require strategic foresight, including reinforcement of sourcing strategies, investment in regional support capabilities, and transparent engagement with buyers about lifecycle costs. Clinical leaders and procurement teams should prioritize devices that demonstrate interoperability, security, and measurable impact on clinical workflows. Ultimately, the most successful solutions will be those that deliver reliable, user-friendly imaging in contexts where speed and access materially improve patient outcomes and system efficiency.

By aligning product development with validated clinical needs and by building resilient commercial and operational infrastructures, stakeholders can accelerate adoption and sustainably embed portable diagnostic imaging into diverse care pathways. The sector's momentum offers a compelling opportunity for those willing to invest in evidence, serviceability, and platform-driven value creation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Portable Diagnostic Imaging Market, by Product Type

  • 8.1. CT
    • 8.1.1. Cone Beam CT
    • 8.1.2. Helical CT
  • 8.2. Molecular Imaging
    • 8.2.1. PET
    • 8.2.2. SPECT
  • 8.3. MRI
    • 8.3.1. High Field
    • 8.3.2. Mid Field
    • 8.3.3. Ultra Low Field
  • 8.4. Ultrasound
    • 8.4.1. 2D
    • 8.4.2. 3D
    • 8.4.3. Doppler
    • 8.4.4. Handheld
      • 8.4.4.1. Dedicated Device
      • 8.4.4.2. Smartphone Based
    • 8.4.5. Wireless
      • 8.4.5.1. Bluetooth Enabled
      • 8.4.5.2. Wi-Fi Enabled
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography

9. Portable Diagnostic Imaging Market, by Portability Type

  • 9.1. Handheld
    • 9.1.1. Dedicated Device
    • 9.1.2. Smartphone Based
  • 9.2. Laptop Based
    • 9.2.1. Standard Integration
    • 9.2.2. Tablet Integration
  • 9.3. Trolley Based
    • 9.3.1. AC Operated
    • 9.3.2. Battery Operated

10. Portable Diagnostic Imaging Market, by Application

  • 10.1. Emergency
    • 10.1.1. Critical Care
    • 10.1.2. Trauma
  • 10.2. Home Care
    • 10.2.1. Chronic Disease Monitoring
    • 10.2.2. Elderly Care
  • 10.3. Military
    • 10.3.1. Combat Zone
    • 10.3.2. Field Hospital
  • 10.4. Point Of Care
    • 10.4.1. Abdominal
    • 10.4.2. Cardiology
    • 10.4.3. Musculoskeletal
    • 10.4.4. Obstetrics
    • 10.4.5. Vascular
  • 10.5. Veterinary
    • 10.5.1. Large Animal
    • 10.5.2. Small Animal

11. Portable Diagnostic Imaging Market, by End User

  • 11.1. Clinics
    • 11.1.1. Government
    • 11.1.2. Private
  • 11.2. Diagnostic Centers
    • 11.2.1. Imaging Centers
    • 11.2.2. Laboratories
  • 11.3. Home Care Providers
    • 11.3.1. Private
    • 11.3.2. Public
  • 11.4. Hospitals
    • 11.4.1. General
    • 11.4.2. Specialty
  • 11.5. Outpatient Centers
    • 11.5.1. Ambulatory Surgical
    • 11.5.2. Rehabilitation

12. Portable Diagnostic Imaging Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Portable Diagnostic Imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Portable Diagnostic Imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Portable Diagnostic Imaging Market

16. China Portable Diagnostic Imaging Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Agfa-Gevaert N.V.
  • 17.7. Akumin Inc
  • 17.8. Butterfly Network, Inc.
  • 17.9. Canon Medical Systems Corporation
  • 17.10. Carestream Health, Inc.
  • 17.11. Cobalt Health
  • 17.12. CurveBeam LLC
  • 17.13. Esaote S.p.A
  • 17.14. Esaote SpA
  • 17.15. Front Range Mobile Imaging
  • 17.16. FUJIFILM Holdings Corporation
  • 17.17. GE HealthCare Technologies Inc
  • 17.18. Hitachi Ltd.
  • 17.19. Hologic, Inc.
  • 17.20. Hyperfine Inc.
  • 17.21. Koninklijke Philips N.V.
  • 17.22. Medtronic PLC
  • 17.23. Nox Medical
  • 17.24. OMRON Corporation
  • 17.25. Shimadzu Corporation
  • 17.26. Siemens Healthineers AG
  • 17.27. Toshiba Medical Systems Corporation
  • 17.28. TridentCare, LLC
  • 17.29. TTG Imaging Solutions, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LARGE ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LARGE ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LARGE ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMALL ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMALL ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMALL ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AMBULATORY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AMBULATORY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AMBULATORY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2032 (USD MILLION)
  • TABLE 235. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2032 (USD MILLION)
  • TABLE 237. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 238. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2032 (USD MILLION)
  • TABLE 239. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 240. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
  • TABLE 241. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 243. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 245. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2032 (USD MILLION)
  • TABLE 260. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2032 (USD MILLION)
  • TABLE 262. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2032 (USD MILLION)
  • TABLE 264. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
  • TABLE 266. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 268. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 270. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2032 (USD MILLION)
  • TABLE 284. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 288. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 290. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY VETERINARY, 2018-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 294. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 296. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY OUTPATIENT CENTERS, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGIN